We encourage companies
that project change
t

t
@CaixaCR

N

News & events

Aelix Therapeutics completes Series A funding of €11.5M ($12.7M) for therapeutic HIV vaccine

11.01.2016

Funds will support proof of concept studies for lead candidate HTI immunogen as a therapeutic vaccine against HIV infection

Continue reading...

Other news See all news »